OrbiMed Advisors LLC's Form 4 filing
Theseus Pharmaceuticals, Inc. (THRX) · filed Jan 13, 2022
- Accession no.
- 0000947871-22-000047
- Filed
- Jan 13, 2022, 7:18 PM ET
- Trade date
- Jan 11-13, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $442.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | Director, 10% Owner |
| OrbiMed Capital GP VII LLCCIK 0001760648 | Director, 10% Owner |
| OrbiMed Genesis GP LLCCIK 0001808744 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 11, 2022 | Common Stock | PPurchaseAcquired | +1,600 | $9.81F1 | +$15,696 | 16,341,118 | Indirect | Duplicate filing |
| Jan 11, 2022 | Common Stock | PPurchaseAcquired | +6,900 | $10.67F3 | +$73,623 | 16,348,018 | Indirect | Duplicate filing |
| Jan 12, 2022 | Common Stock | PPurchaseAcquired | +18,897 | $10.06F4 | +$190,103.82 | 16,366,915 | Indirect | Duplicate filing |
| Jan 13, 2022 | Common Stock | PPurchaseAcquired | +17,320 | $9.43F5 | +$163,327.6 | 16,384,235 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares of the Issuer's common stock ("Shares") were purchased in a block order at price of $9.81.
Referenced by the price of 1 transaction in Table I.
- F3
These Shares were purchased in a block order at price of $10.67.
Referenced by the price of 1 transaction in Table I.
- F4
These Shares were purchased in a block order at price of $10.06.
Referenced by the price of 1 transaction in Table I.
- F5
These Shares were purchased in a block order at price of $9.43.
Referenced by the price of 1 transaction in Table I.